| Literature DB >> 20960436 |
Estelle Dellapina1, Angélique Gerdelat-Mas, Fabienne Ory-Magne, Laure Pourcel, Monique Galitzky, Fabienne Calvas, Marion Simonetta-Moreau, Claire Thalamas, Pierre Payoux, Christine Brefel-Courbon.
Abstract
Patients with Parkinson's disease (PD) frequently experience pain that could be in part due to central modification of nociception. In this randomized controlled double blind study, we compared the effect of apomorphine versus placebo on pain thresholds and pain-induced cerebral activity in 25 patients with PD. Subjective pain threshold (using thermal stimulation, thermotest), objective pain threshold (nociceptive flexion reflex), and cerebral activity (H(2)(15)O PET) during noxious and innocuous stimulations were performed. Neither subjective nor objective pain thresholds nor pain activation profile were modified by apomorphine compared with placebo in 25 PD patients. Apomorphine has no effect on pain processing in PD. We suggest that other monoamine systems than dopaminergic system could be involved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20960436 DOI: 10.1002/mds.23406
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338